Hypogonadism

Endocrinology·MeSH: Hypogonadism

10 drugs in development·7 companies·2 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
aveed	Endo LP (NDOI)
estradiol	Amneal Pharmaceuticals, Inc. (AMRX)
testosterone	Amneal Pharmaceuticals, Inc. (AMRX)
testosterone enanthate	NEXUS BIOPHARMA INC (NEXS)

Phase 2(4)

Drug	Company
GnRH	ENANTA PHARMACEUTICALS INC (ENTA)
kisspeptin 112-121	ENANTA PHARMACEUTICALS INC (ENTA)
leflutrozole	Mereo BioPharma Group plc (MREO)
testosterone 1.62% gel	GH Research PLC (GHRS)

Phase 1(1)

Drug	Company
zoladex	GH Research PLC (GHRS)

Preclinical(1)

Drug	Company
ias-167a	IASO BIOMED, INC. (IASO)

BioSniper tracks 10 drugs in development for Hypogonadism across 7 companies.

There are 2 clinical trials targeting Hypogonadism tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.